Navigation Links
Barry Bloom, Jeffrey Sachs to Be Honored for Introducing Modern Solutions to The World's Oldest Problems: Poverty And Disease
Date:9/2/2009

NEW YORK, Sept. 2 /PRNewswire-USNewswire/ -- The Prix Galien USA committee will recognize Barry R. Bloom, Ph.D., of Harvard University and Jeffrey D. Sachs, Ph.D., of Columbia University with its 2009 Pro Bono Humanum Award for bringing the best of modern biological and economic science to the poorest corners of the globe.

"Barry Bloom and Jeffrey Sachs are leaders in innovation who have applied science and economics to global health problems in ways that have changed the lives of the world's most impoverished people," said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal. "We have much to learn from their approach to improving the human condition: Analysis and prevention are cheaper in both human and financial terms than intervention after poverty and disease take their toll."

Dr. Bloom will be honored for the scientific contributions he has made to understanding immune responses to infectious diseases like leprosy, tuberculosis and malaria. His work has supported efforts to eradicate disease and lessen the burden of infectious disease on impoverished countries. He is a Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health at the Harvard School of Public Health. He has been extensively involved in the World Health Organization for more than 40 years.

Dr. Sachs will be honored for the Millennium Villages, a project which has helped rural African communities and close to half a million people lift themselves out of extreme poverty. By providing a basic set of interventions that addresses needs in business development, food, health, infrastructure and education, the project has produced great results including increases in crop yields and school enrollment, as well as major drops in malaria incidences. Sachs was named by Time Magazine as one of the most influential leaders in the world, and is the director of The Earth Institute, Quetelet Professor of Sustainable Development, and professor of health policy and management at Columbia University.

The Prix Galien USA recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines. The award committee comprises 11 individuals including seven Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. Recipients of the 2009 Prix Galien USA will be honored at its annual gala event on September 30 emceed by Charlie Rose at the American Museum of Natural History in New York. Prior to the event, the committee will host a roundtable discussion about improving human health through innovative science and clinical research featuring Prix Galien USA candidates and Pro Bono Humanum winners.

For more information about the 2009 Prix Galien USA, visit www.prix-galien-usa.com.


'/>"/>
SOURCE Prix Galien USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Michael Barry of MGH is New President of Foundation for Informed Medical Decision Making
2. PDL BioPharma Elects Barry Selick to Its Board of Directors
3. Barry Lundquist Named Interim President of Council for Disability Awareness
4. Former U.S. Drug Czar, 4-Star General Barry McCaffrey, to Highlight Vanguard Breakfast Breakthrough Event 8 a.m. Friday, May 1, Washington Golf and Country Club, Arlington
5. Barry Arbuckle, MemorialCare Medical Center CEO and California Hospital Association Past Chair, Speaks Out on Impact of 3-Year, $32 Million Public-Private Partnership
6. Barry Arbuckle, Ph.D., President & CEO of MemorialCare Medical Centers to Chair Southern California March for Babies 2009, March of Dimes Largest Fundraising Events
7. Dr. Barry Friedberg comments on David vs. Goliath: Whos Really in the Pursuit of Patient Safety & Satisfaction?
8. Think About It. Barry Spiegelman Memorial Golf Classic Benefits Brain Cancer Research
9. Zone Diet Creator Dr. Barry Sears to Talk About Latest Book Toxic Fat: When Good Fat Turns Bad
10. Barry Arbuckle, PhD, MemorialCare Medical Centers CEO and Immediate Past Chair, California Hospital Association, Speaks Out on California Budget Passage
11. Barry Skirble Joins Four Rivers Software Systems as Chief Technology Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: